The G20210A Mutation of the Prothrombin Gene in Patients with Previous First Episodes of Deep-Vein Thrombosis: Prevalence and Association with Factor V G1691A, Methylenetetrahydrofolate Reductase C677T and Plasma Prothrombin Levels
- 31 January 1999
- journal article
- Published by Elsevier BV in Thrombosis Research
- Vol. 93 (1), 1-8
- https://doi.org/10.1016/s0049-3848(98)00136-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Thermolabile Methylenetetrahydrofolate Reductase and Factor V Leiden in the Risk of Deep-Vein ThrombosisThrombosis and Haemostasis, 1998
- Hyperhomocysteinemia: A risk factor for arterial and venous thrombotic diseaseInternational Journal of Clinical and Laboratory Research, 1997
- The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic diseaseBritish Journal of Haematology, 1997
- Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′‐untranslated region of the prothrombin geneBritish Journal of Haematology, 1997
- A Common Mutation in the Methylenetetrahydrofolate Reductase Gene (C677T) Increases the Risk for Deep-Vein Thrombosis in Patients With Mutant Factor V (Factor V:Q 506 )Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
- The Mutation Ala677→Val in the Methylene Tetrahydrofolate Reductase Gene: A Risk Factor for Arterial Disease and Venous ThrombosisThrombosis and Haemostasis, 1997
- Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine ConcentrationsCirculation, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient familiesBlood, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994